Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-29 @ 11:25 PM
Study NCT ID:
NCT02293850
Status:
UNKNOWN
Last Update Posted:
2018-08-20
First Post:
2014-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Sponsor:
Oncolys BioPharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-04
Completion Date Type:
ESTIMATED
First Submit Date:
2014-11-13
First Submit QC Date:
None
Study First Post Date:
2014-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-16
Last Update Post Date:
2018-08-20
Last Update Post Date Type:
ACTUAL